Drugs / pneumococcus conjugate vaccine 7 valent
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00580684 Comparator | Sep 2003 → Aug 2004 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pneumococcus conjugate vaccine 7 valent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00580684 ↗ |
| Modality | Vaccine | “pneumococcus conjugate vaccine 7 valent to reduce carriage” NCT00580684 ↗ |